CN110123921A - The preparation method and anti-dengue virus application of banana leaf extract - Google Patents

The preparation method and anti-dengue virus application of banana leaf extract Download PDF

Info

Publication number
CN110123921A
CN110123921A CN201910478232.0A CN201910478232A CN110123921A CN 110123921 A CN110123921 A CN 110123921A CN 201910478232 A CN201910478232 A CN 201910478232A CN 110123921 A CN110123921 A CN 110123921A
Authority
CN
China
Prior art keywords
banana
banana leaf
dengue virus
dengue
leaf extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910478232.0A
Other languages
Chinese (zh)
Other versions
CN110123921B (en
Inventor
邓家刚
侯小涛
郝二伟
李聪
杜正彩
秦建峰
韦玮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangxi University of Chinese Medicine
Original Assignee
Guangxi University of Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangxi University of Chinese Medicine filed Critical Guangxi University of Chinese Medicine
Priority to CN201910478232.0A priority Critical patent/CN110123921B/en
Publication of CN110123921A publication Critical patent/CN110123921A/en
Application granted granted Critical
Publication of CN110123921B publication Critical patent/CN110123921B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses the ethanol extracts of Banana Leaf to have certain inhibition dengue virus effect.Accordingly, inventor has also set up the corresponding extracting method of Banana Leaf ethanol extract.Experiment shows that Banana Leaf ethanol extract has anti-dengue virus effect, to dengue virus IC50For 3.79 μ g/ml.As it can be seen that Banana Leaf has the potential value of anti-dengue drug.Therefore, the present invention provides strong foundation and reliable guarantee further to open up the medical applications of Banana Leaf, and banana resource utilization can be improved, and reduces the wasting of resources;Also Chinese herbal medicine approach is opened for treatment dengue fever, to reduce drug production cost.

Description

香蕉叶提取物的制备方法和抗登革热病毒应用Preparation method of banana leaf extract and anti-dengue virus application

技术领域technical field

本发明属于登革热病毒治疗技术领域,尤其涉及一种香蕉叶提取物的制备方法和抗登革热病毒应用。The invention belongs to the technical field of dengue fever virus treatment, and in particular relates to a preparation method of banana leaf extract and an anti-dengue virus application.

背景技术Background technique

病毒为自然界微生物的一种,按核酸类型分为DNA病毒和RNA病毒两种,其在自然界中分布广泛,可感染细菌、真菌、植物、动物和人,常引起宿主发病。由病毒引起的人患疾病很多,登革热(Dengue fever)为其中一种。Viruses are a kind of microorganisms in nature. They are divided into DNA viruses and RNA viruses according to the type of nucleic acid. They are widely distributed in nature and can infect bacteria, fungi, plants, animals and humans, and often cause disease in the host. People suffer from many diseases caused by viruses, and dengue fever (Dengue fever) is one of them.

登革热是由1~5型登革病毒(Dengue virus,DENV)引起并通过埃及伊蚊或白纹伊蚊叮咬传播的急性蚊媒传染病。该病流行往往呈暴发性,发病率高,但病死率较低,严重患者表现为血管渗透性增加、低血容量和凝血机制异常等,重症患者可导致死亡。该病主要发生在全世界热带和亚热带地区,近年来DF疫情呈上升趋势,WHO统计资料显示,全球约有25~40亿人受到DENV感染的威胁,估计每年发病达0.5~1亿例,全球近3亿人发生DENV隐性感染。目前全球发生DF疫情已有128个国家,DF在非洲、美洲、东地中海、东南亚和西太平洋100多个国家呈地方性流行,以美洲、东南亚和西太平洋地区更为严重,随着国际交流的深入,DF已成为全球严重的公共卫生问题。自1978年以来,我国由输入病例引起的DF暴发流行时有发生,广东、广西、云南、福建和河南等省均报告由输入病例引起的DF暴发,严重威胁着我国人民的健康生活。Dengue fever is an acute mosquito-borne infectious disease caused by dengue virus (DENV) types 1-5 and transmitted through the bite of Aedes aegypti or Aedes albopictus. The prevalence of the disease is often fulminant, with a high morbidity rate, but a low case fatality rate. Severe cases show increased vascular permeability, hypovolemia, and abnormal coagulation mechanisms. Severe cases can lead to death. The disease mainly occurs in tropical and subtropical regions of the world. In recent years, the DF epidemic has been on the rise. According to WHO statistics, about 2.5 to 4 billion people in the world are threatened by DENV infection. Nearly 300 million people have DENV recessive infection. At present, DF epidemics have occurred in 128 countries around the world. DF is endemic in more than 100 countries in Africa, the Americas, the Eastern Mediterranean, Southeast Asia and the Western Pacific, and it is more serious in the Americas, Southeast Asia and the Western Pacific. In-depth, DF has become a serious global public health problem. Since 1978, outbreaks of DF caused by imported cases have occurred frequently in my country. Guangdong, Guangxi, Yunnan, Fujian, Henan and other provinces have reported DF outbreaks caused by imported cases, which seriously threaten the healthy life of our people.

目前,登革热尚无疫苗可供预防,临床上还没有确切有效的病原治疗药物,只能以对症治疗为主,因此研究抗登革病毒药物为目前工作的重点。At present, there is no vaccine available for prevention of dengue fever, and there is no exact and effective pathogenic treatment drug in clinical practice, and only symptomatic treatment is given priority to. Therefore, research on anti-dengue virus drugs is the focus of current work.

香蕉(Musa nana Lour.)是芭蕉科芭蕉属多年生大型单子叶草本植物,广泛分布于南北纬30°以下的热带、亚热带地区。香蕉属高热量水果,果肉富含碳水化合物、蛋白质、脂肪、膳食纤维、多种微量元素以及维生素,为仅次于水稻、小麦和玉米的世界第四大粮食作物。大约有136个国家和地区生产香蕉,主产区集中在印度、菲律宾、中国、巴西等国。近年来,世界香蕉收获面积和产量均呈不断增长的趋势,在收获大量香蕉产品的同时也产生几乎等量的香蕉茎叶等农业废弃物。为此,如何对香蕉茎叶进行回收利用已成为一个亟待解决的课题。香蕉茎叶体积大,因而收集劳动强度高;含水量高,既不能直接燃烧又增加运输成本;但其本身具有较高的生物量,营养物质丰富,拥有巨大的开发潜力。目前大部分的香蕉茎秆、叶片等被用作饲料、肥料,或者用来生产低档纸、粗布、包装绳等产品,进一步则可发酵生产沼气或者酒精。而其药用价值的开发则鲜有报道,特别是用于抗病毒的研究则未见相关报道。Banana (Musa nana Lour.) is a perennial large-scale monocotyledonous herbaceous plant of the genus Musa in the Musa family. It is widely distributed in tropical and subtropical regions below 30° north and south latitude. Banana is a high-calorie fruit. The pulp is rich in carbohydrates, protein, fat, dietary fiber, various trace elements and vitamins. It is the fourth largest food crop in the world after rice, wheat and corn. About 136 countries and regions produce bananas, and the main production areas are concentrated in India, the Philippines, China, Brazil and other countries. In recent years, the harvested area and output of bananas in the world have shown a continuous growth trend. While harvesting a large number of banana products, almost the same amount of agricultural waste such as banana stems and leaves is produced. For this reason, how to recycle banana stems and leaves has become an urgent problem to be solved. Banana stems and leaves are bulky, so the collection labor intensity is high; the water content is high, which can neither be burned directly nor increase the transportation cost; but it has high biomass and rich nutrients, and has huge development potential. At present, most of the banana stems and leaves are used as feed, fertilizer, or used to produce low-grade paper, coarse cloth, packaging rope and other products, and further can be fermented to produce biogas or alcohol. However, there are few reports on the development of its medicinal value, especially for antiviral research.

发明内容Contents of the invention

本发明要解决的技术问题是提供一种香蕉叶提取物的制备方法和抗登革热病毒应用,以充分发掘废弃物香蕉叶的医药价值,为治疗登革热开辟中草药途径。The technical problem to be solved by the present invention is to provide a preparation method of banana leaf extract and anti-dengue fever virus application, so as to fully explore the medical value of waste banana leaves and open up a way of Chinese herbal medicine for the treatment of dengue fever.

为解决上述技术问题,本发明采用以下技术方案:In order to solve the problems of the technologies described above, the present invention adopts the following technical solutions:

香蕉叶提取物在制备抗登革热病毒药物中的应用。Application of banana leaf extract in preparation of anti-dengue virus medicine.

登革热病毒为登革2型病毒。Dengue virus is dengue type 2 virus.

香蕉叶提取物为香蕉叶的乙醇提取物。Banana leaf extract is the ethanol extract of banana leaves.

香蕉叶提取物的制备方法,取香蕉叶加乙醇超声提取,过滤,抽滤,滤液旋蒸回收溶剂至浓缩液状后,离心至干膏即得。The preparation method of the banana leaf extract comprises the following steps: taking banana leaves and adding ethanol for ultrasonic extraction, filtering, suction filtering, rotating the filtrate to recover the solvent to a concentrated liquid state, and centrifuging until the dry paste is obtained.

香蕉叶为香蕉叶绿色叶片部位鲜品。The banana leaf is a fresh product of the green leaf part of the banana leaf.

乙醇为体积浓度95%的乙醇,加入量为8倍香蕉叶重量。The ethanol is ethanol with a volume concentration of 95%, and the addition amount is 8 times of the banana leaf weight.

超声提取2h,旋蒸温度为40℃。Ultrasonic extraction was carried out for 2 hours, and the rotary steaming temperature was 40°C.

针对目前农作物废弃物香蕉叶价值尚未得到有效开发的问题,发明人经深入研究发现,香蕉叶的乙醇提取物具有一定的抑制登革病毒作用。据此,发明人还建立了香蕉叶乙醇提取物的相应提取方法。实验表明,香蕉叶乙醇提取物具有抗登革病毒效果,其对登革病毒IC50为3.79μg/ml。可见,香蕉叶具有抗登革热药物的潜在价值。因此,本发明为进一步开辟香蕉叶的医药应用提供了有力依据和可靠保障,可提高香蕉资源利用率,减少资源浪费;也为治疗登革热开辟了中草药途径,以降低药物生产成本。Aiming at the problem that the value of banana leaves, the agricultural wastes, has not been effectively exploited, the inventors have found through in-depth research that the ethanol extract of banana leaves has a certain inhibitory effect on dengue virus. Accordingly, the inventor has also established a corresponding extraction method of the banana leaf ethanol extract. Experiments show that the ethanol extract of banana leaves has anti-dengue virus effect, and its IC 50 against dengue virus is 3.79 μg/ml. It can be seen that banana leaves have the potential value of anti-dengue drugs. Therefore, the present invention provides a strong basis and reliable guarantee for further developing the medical application of banana leaves, which can improve the utilization rate of banana resources and reduce waste of resources; it also opens up a way of Chinese herbal medicine for the treatment of dengue fever, so as to reduce the cost of drug production.

附图说明Description of drawings

图1是本发明香蕉叶的乙醇提取物抗登革病毒空斑试验结果图。Fig. 1 is the result figure of the anti-dengue virus plaque test of the ethanol extract of banana leaf of the present invention.

图2是本发明香蕉叶的乙醇提取物抗基孔肯雅病毒空斑试验结果图。Fig. 2 is a graph showing the results of the anti-chikungunya virus plaque test of the ethanol extract of banana leaves of the present invention.

图3是本发明香蕉叶的乙醇提取物对登革病毒及基孔肯雅病毒抑制率结果图。Fig. 3 is the result chart of the inhibition rate of dengue virus and chikungunya virus by ethanol extract of banana leaves of the present invention.

具体实施方式Detailed ways

一、实验材料1. Experimental materials

1.香蕉叶提取物1. Banana Leaf Extract

取香蕉叶绿色叶片部位鲜品100.00g,加8倍量95%乙醇,超声提取2h,过滤后定性滤纸抽滤,取滤液置于旋转蒸发仪上40℃回收溶剂,至浓缩液状后,置于40℃离心浓缩,得787.40mg干膏备用。Take 100.00g fresh product from the green leaf part of banana leaf, add 8 times the amount of 95% ethanol, ultrasonically extract for 2 hours, filter and filter with qualitative filter paper, take the filtrate and put it on a rotary evaporator at 40°C to recover the solvent, until it is concentrated liquid, put it in Concentrate by centrifugation at 40°C to obtain 787.40 mg of dry paste for future use.

2.病毒株2. Virus strains

登革病毒、基孔肯雅病毒。Dengue virus, Chikungunya virus.

3.细胞株3. Cell lines

人肝癌细胞Huh-7、人宫颈癌细胞Hela、乳仓鼠肾细胞BHK21。Human liver cancer cells Huh-7, human cervical cancer cells Hela, and suckling hamster kidney cells BHK21.

4.主要试剂与仪器4. Main reagents and instruments

DMEM培养基、RPMI-1640培养基、FBS、Trypsin、alamar Blue、细胞培养板、DMSO、结晶紫溶液、离心浓缩仪、旋转蒸发仪、生物安全柜、CO2培养箱、移液枪、酶标仪。DMEM medium, RPMI-1640 medium, FBS, Trypsin, alamar Blue, cell culture plate, DMSO, crystal violet solution, centrifugal concentrator, rotary evaporator, biological safety cabinet, CO2 incubator, pipette gun, microplate reader .

二、实验方法2. Experimental method

1.药物细胞毒性试验1. Drug Cytotoxicity Test

(1)取对数生长期的Huh-7(Hela)肿瘤细胞适量至75ml培养瓶中,37℃培养至细胞生长状态良好,Trypsin消化细胞后按6.5×103个/孔(1.3×104个/孔)的细胞量接种于96孔板中,继续培养24h,备用。(1) Take an appropriate amount of Huh-7 (Hela) tumor cells in the logarithmic growth phase and put them in a 75ml culture flask, culture them at 37°C until the cells grow well, digest the cells with Trypsin at 6.5×10 3 cells/well (1.3×10 4 cells/well) were inoculated in a 96-well plate, continued to culture for 24 h, and were set aside.

(2)将各提取物用DMSO溶解之后,用含血清的DMEM培养基配制成药物浓度为100.00μg/ml、50.00μg/ml、25.00μg/ml、12.50μg/ml、6.25μg/ml的含药培养基,备用。0.1%DMSO作为溶剂对照。(2) After dissolving each extract with DMSO, use serum-containing DMEM medium to prepare drug concentrations of 100.00 μg/ml, 50.00 μg/ml, 25.00 μg/ml, 12.50 μg/ml, 6.25 μg/ml containing Medicine culture medium, spare. 0.1% DMSO was used as solvent control.

(3)取出已经培养24h的细胞,倾去96孔板中的培养基,加入含药物培养基,每个样品每个浓度设3个平行,另设模型组及溶剂对照组,模型组加入不含药培养基,溶剂对照组加入含0.1%DMSO的培养基,均设3个平行,继续37℃培养48h。(3) Take out the cells that have been cultured for 24 hours, discard the medium in the 96-well plate, add the medium containing the drug, set 3 parallels for each concentration of each sample, and set up a model group and a solvent control group separately. The drug-containing medium and the medium containing 0.1% DMSO were added to the solvent control group, and three parallel sets were set up, and culture was continued at 37°C for 48h.

(4)取出培养48h后的细胞,倾去培养基,均加入100μl(1:10配置)的alamar bule溶液,另取三个孔加入相同量的alamar blue溶液作为空白组,37℃孵育2h(以模型组颜色完全变化为粉红色为度),取出后于酶标仪(激发波长570nm,发射波长585nm)检测荧光度值。(4) Take out the cells cultured for 48 hours, discard the culture medium, add 100 μl (1:10 configuration) of alamar bule solution, add the same amount of alamar blue solution to another three wells as a blank group, and incubate at 37°C for 2 hours ( The color of the model group has completely changed to pink as the degree), and after taking it out, detect the fluorescence value in a microplate reader (excitation wavelength 570nm, emission wavelength 585nm).

计算公式为:(含药物组荧光度值平均值-空白组荧光度值平均值)/(模型组荧光度值平均值-空白组荧光度值平均值)×100%The calculation formula is: (the average value of the fluorescence value of the drug-containing group-the average value of the fluorescence value of the blank group)/(the average value of the fluorescence value of the model group-the average value of the fluorescence value of the blank group)×100%

2.抗病毒药效试验2. Antiviral efficacy test

(1)取培养至对数生长期的Huh-7(Hela)细胞,消化后按5×104个/孔(7×104个/孔)的量加至24孔板中,培养24h。(1) Huh-7 (Hela) cells cultured to the logarithmic growth phase were taken, digested and added to a 24-well plate at an amount of 5×10 4 cells/well (7×10 4 cells/well), and cultured for 24 hours.

(2)取出培养了24h的24孔板,倾去每个孔中的培养基。37℃水浴解冻DENV-2(CHIKV)病毒30s~1min,用DMEM培养基配制成含病毒为5×105PFU/ml(7×105PFU/ml)的稀释液,往每孔加入100μl病毒稀释液使接种于24孔板中每个孔的病毒单位为5×104PFU(7×104PFU),37℃孵育1h,取出后加PBS清洗两次。然后进行给药,香蕉叶提取物给药浓度参考细胞毒性实验中的安全浓度(给药后Huh-7/Hela细胞存活率≥80%),即为6.25μg/ml、12.50μg/ml、25.00μg/ml、50.00μg/ml。设三个平行孔,以0.1%DMSO为溶剂对照组,每孔给药体积1ml。37℃培养48h,培养结束后将每个孔中的培养基吸出装至1.5ml的离心管中做标记后,-80℃保存。(2) Take out the 24-well plate that has been cultured for 24 hours, and pour off the medium in each well. Thaw DENV-2 (CHIKV) virus in a water bath at 37°C for 30 seconds to 1 minute, prepare a virus-containing dilution of 5×10 5 PFU/ml (7×10 5 PFU/ml) with DMEM medium, and add 100 μl of virus to each well The dilution solution made the virus unit inoculated in each well of the 24-well plate 5×10 4 PFU (7×10 4 PFU), incubated at 37° C. for 1 hour, took it out, and washed it twice with PBS. Administration is then carried out, and the administration concentration of banana leaf extract refers to the safe concentration in the cytotoxicity experiment (Huh-7/Hela cell survival rate ≥ 80% after administration), which is 6.25 μg/ml, 12.50 μg/ml, 25.00 μg/ml, 50.00μg/ml. Three parallel wells were set up, 0.1% DMSO was used as the solvent control group, and the volume of administration in each well was 1 ml. Cultivate at 37°C for 48h, after the end of the culture, suck out the culture medium in each well and put it into a 1.5ml centrifuge tube for marking, then store at -80°C.

(3)取处于对数生长期的BHK21细胞,消化后按5×104个/孔的量加至24孔板中,每个流分每个浓度需要接种6孔,培养24h。培养结束后取出,倾倒培养基。取出(2)项下-80℃保存的含病毒样本,每个样品均需按10倍梯度稀释成6个浓度,分别为10-1、10-2、10-3、10-4、10-5、10-6,将每个稀释后的含病毒稀释液分别按100μl/孔的剂量加入至培养好的BHK21细胞中,37℃孵育1h,取出后加入PBS清洗两次,之后再加入培养基(1%CMC+2%FBS)1ml/孔。37℃培养6d(4d)。取出后倒去培养基,加入结晶紫溶液,摇床震摇过夜。倒去结晶紫溶液,清水清洗后擦干,进行空斑计数。(3) BHK21 cells in the logarithmic growth phase were taken, and after digestion, 5×10 4 cells/well were added to a 24-well plate. Each fraction and concentration needed to inoculate 6 wells, and cultured for 24 hours. After the cultivation, take it out and pour out the culture medium. Take out the virus-containing samples stored at -80°C under item (2), and each sample needs to be diluted into 6 concentrations according to a 10-fold gradient, which are 10 -1 , 10 -2 , 10 -3 , 10 -4 , 10 - 5 , 10 -6 , each diluted virus-containing dilution was added to the cultured BHK21 cells at a dose of 100 μl/well, incubated at 37°C for 1 hour, removed and washed twice with PBS, and then added to the culture medium (1% CMC+2% FBS) 1 ml/well. Incubate at 37°C for 6d (4d). After taking it out, pour out the medium, add crystal violet solution, and shake overnight on a shaker. Pour off the crystal violet solution, wash with water and dry, and count the plaques.

(4)取已擦干的24孔板,肉眼计数,记录空斑数量为1~20个之间的孔相应的空斑数,按给药组与对照组的总空斑数的对数值进行比较(总空斑数=肉眼空斑数×对应的稀释倍数×10),以对照组空斑数对数值的均值-给药组空斑数对数值的均值≥1为药物在该浓度下具有显著抗病毒作用,若1≥对照组空斑数对数值的均值-给药组空斑数对数值的均值≥0.5则表示药物在该浓度下具有抗病毒效果,同时根据抑制率计算IC50值。(4) Take the dried 24-well plate, count with the naked eye, record the number of plaques corresponding to the wells with 1 to 20 plaques, and perform the logarithm of the total number of plaques in the treatment group and the control group Comparison (total plaque number = naked eye plaque number × corresponding dilution factor × 10), the mean value of the logarithmic value of the plaque number in the control group - the mean value of the logarithmic value of the plaque number in the administration group ≥ 1 means that the drug has the effect at this concentration Significant antiviral effect, if 1 ≥ the mean value of the logarithmic value of the plaque number in the control group - the mean value of the logarithmic value of the plaque number in the treatment group ≥ 0.5, it means that the drug has an antiviral effect at this concentration, and the IC50 value is calculated based on the inhibition rate.

三、实验结果3. Experimental results

如图1至图3所示,香蕉叶提取物给药浓度大于或等于12.50μg/ml时具有抗病毒效果,给药浓度为50.00μg/ml时均能完全抑制病毒增殖,香蕉叶对登革病毒IC50为3.79μg/ml,对基孔肯雅病毒IC50为8.73μg/ml。As shown in Figures 1 to 3, banana leaf extract has an antiviral effect when the administration concentration is greater than or equal to 12.50 μg/ml, and can completely inhibit virus proliferation when the administration concentration is 50.00 μg/ml. The IC 50 of the virus was 3.79 μg/ml, and the IC 50 of Chikungunya virus was 8.73 μg/ml.

Claims (7)

1.香蕉叶提取物在制备抗登革热病毒药物中的应用。1. Application of banana leaf extract in the preparation of anti-dengue virus medicine. 2.根据权利要求1所述应用,其特征在于:所述登革热病毒为登革2型病毒。2. The application according to claim 1, characterized in that: the dengue virus is dengue type 2 virus. 3.根据权利要求1所述应用,其特征在于:所述香蕉叶提取物为香蕉叶的乙醇提取物。3. The application according to claim 1, characterized in that: the banana leaf extract is the ethanol extract of banana leaves. 4.一种香蕉叶提取物的制备方法,其特征在于:取香蕉叶加乙醇超声提取,过滤,抽滤,滤液旋蒸回收溶剂至浓缩液状后,离心至干膏即得。4. A preparation method of banana leaf extract, which is characterized in that: take banana leaves and add ethanol for ultrasonic extraction, filter, suction filter, spin the filtrate to recover the solvent to a concentrated liquid, and then centrifuge to a dry paste. 5.根据权利要求4所述的香蕉叶提取物的制备方法,其特征在于:所述香蕉叶为香蕉叶绿色叶片部位鲜品。5. the preparation method of banana leaf extract according to claim 4 is characterized in that: described banana leaf is the fresh product of green leaf part of banana leaf. 6.根据权利要求5所述的香蕉叶提取物的制备方法,其特征在于:所述乙醇为体积浓度95%的乙醇,加入量为8倍香蕉叶重量。6. the preparation method of banana leaf extract according to claim 5 is characterized in that: described ethanol is the ethanol of volume concentration 95%, and add-on is 8 times of banana leaf weight. 7.根据权利要求6所述的香蕉叶提取物的制备方法,其特征在于:所述超声提取2h,旋蒸温度为40℃。7. The method for preparing the banana leaf extract according to claim 6, characterized in that: the ultrasonic extraction takes 2 hours, and the rotary steaming temperature is 40°C.
CN201910478232.0A 2019-06-03 2019-06-03 Preparation method of banana leaf extract and application of banana leaf extract in resisting dengue fever virus Active CN110123921B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910478232.0A CN110123921B (en) 2019-06-03 2019-06-03 Preparation method of banana leaf extract and application of banana leaf extract in resisting dengue fever virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910478232.0A CN110123921B (en) 2019-06-03 2019-06-03 Preparation method of banana leaf extract and application of banana leaf extract in resisting dengue fever virus

Publications (2)

Publication Number Publication Date
CN110123921A true CN110123921A (en) 2019-08-16
CN110123921B CN110123921B (en) 2022-03-01

Family

ID=67579939

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910478232.0A Active CN110123921B (en) 2019-06-03 2019-06-03 Preparation method of banana leaf extract and application of banana leaf extract in resisting dengue fever virus

Country Status (1)

Country Link
CN (1) CN110123921B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004083526A (en) * 2002-08-28 2004-03-18 Morinaga Milk Ind Co Ltd Antiviral composition
CN106336390A (en) * 2016-08-25 2017-01-18 岑健 Method for extracting flavone from banana leaves

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004083526A (en) * 2002-08-28 2004-03-18 Morinaga Milk Ind Co Ltd Antiviral composition
CN106336390A (en) * 2016-08-25 2017-01-18 岑健 Method for extracting flavone from banana leaves

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MICHAEL D. SWANSON ETAL.: "A Lectin Isolated from Bananas Is a Potent Inhibitor of HIV Replication", 《THE JOURNAL OF BIOLOGICAL CHEMISTRY》 *

Also Published As

Publication number Publication date
CN110123921B (en) 2022-03-01

Similar Documents

Publication Publication Date Title
Knox et al. Anti‐influenza virus activity of crude extract of Ribes nigrum L.
CN108926584A (en) The antimicrobial purposes of chimonanthea extract
CN107737201A (en) Lemna paucicostata antivirus action application
CN107260774A (en) The purposes of wax-cakes bait Genes For Plant Tolerance pathogenic infection
CN110123921A (en) The preparation method and anti-dengue virus application of banana leaf extract
CN104998022A (en) Dragon's blood tree leaf extract product, and preparation method, pharmaceutical composition, preparation, and applications thereof
CN112274541A (en) Application of semiliquidambar cathayensis or extract thereof in preparation of antitumor drugs
CN112402480A (en) Preparation method and application of eucommia male flower extract with anti-fatigue effect
Su et al. Antiviral activity and constituent of Ardisia chinensis benth against coxsackie B3 virus
CN110448623B (en) Preparation method and anti-chikungunya virus application of banana leaf extract
CN102174095A (en) Malania oleifera lectin and method for preparing same
CN104435062B (en) A kind of blueberry wine mud extract for inducing apoptosis on hepatic stellate cells and its preparation technology and application
CN114668792A (en) Extraction method and application of paper mulberry extract
CN106421722A (en) Traditional Chinese medicine composition and application thereof
CN106177035B (en) Preparation method and application of effective rosa chinensis flower extract with blood sugar reducing and anticancer functions
CN113662974A (en) A kind of preparation and purification method of rhombohedral polyphenol extract
CN107050053A (en) A kind of Contained Serum prepared by Ligusticum wallichii alcohol extract and its preparation method and application
CN105998083A (en) Arenobufagin extraction method and arenobufagin product
CN113181229B (en) Application of cabbage type rape-isatis tinctoria G monomer addition system in inhibiting novel coronavirus SARS-CoV-2
Singh et al. Phytochemical Analysis and Antimicrobial Activity of Various Indigenous Plant Species
CN118453735B (en) Tibetan medicine formula for resisting porcine pseudorabies virus and preparation method thereof
CN102318651B (en) Nematicidal extract of radix-polygoni multiflori and preparation method thereof
CN107296840B (en) Cape jasmine and fermented soybean soup effective part and application thereof in preparation of neuroprotective drugs
CN107115370B (en) The purposes of the anti-enterovirus of wintersweet platymiscium
CN1883530B (en) Laggera extracts with anti-virus, anti-inflammation and/or antibiotic functions and use thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant